These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15999261)

  • 1. CAM for cancer?
    Ernst E
    Support Care Cancer; 2005 Sep; 13(9):669-70. PubMed ID: 15999261
    [No Abstract]   [Full Text] [Related]  

  • 2. The behaviors of seeking a second opinion from other health-care professionals and the utilization of complementary and alternative medicine in gynecologic cancer patients.
    Tam KF; Cheng DK; Ng TY; Ngan HY
    Support Care Cancer; 2005 Sep; 13(9):679-84. PubMed ID: 16032409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution.
    Yoshimura K; Ueda N; Ichioka K; Matsui Y; Terai A; Arai Y
    Support Care Cancer; 2005 Sep; 13(9):685-90. PubMed ID: 15947954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.
    Klafke N; Mahler C; von Hagens C; Rochon J; Schneeweiss A; Müller A; Salize HJ; Joos S
    Trials; 2015 Feb; 16():51. PubMed ID: 25887713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Securing global access to innovations in women's cancer care and control.
    Konecny GE
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):1-3. PubMed ID: 26642066
    [No Abstract]   [Full Text] [Related]  

  • 6. Using a randomised controlled trial (RCT) methodology in CAM research with gynaecological cancer patients: A commentary on the perks and pitfalls.
    Archer S; Forshaw MJ
    Complement Ther Clin Pract; 2015 Feb; 21(1):11-8. PubMed ID: 25582376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the First Global Genito-Urinary Oncology Conference. October 2-3, 2004. Honolulu, Hawaii, USA.
    Can J Urol; 2005 Feb; 12 Suppl 1():1-105. PubMed ID: 15780156
    [No Abstract]   [Full Text] [Related]  

  • 8. Proportion of gynecologic cancer patients using complementary and alternative medicine.
    Supoken A; Chaisrisawatsuk T; Chumworathayi B
    Asian Pac J Cancer Prev; 2009; 10(5):779-82. PubMed ID: 20104968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment decisions: a qualitative study with women with gynaecological cancer.
    Markovic M; Manderson L; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):46-8. PubMed ID: 16441693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in referral and use of complementary and alternative medicine between pediatric providers and patients.
    Jenkins BN; Vincent N; Fortier MA
    Complement Ther Med; 2015 Jun; 23(3):462-8. PubMed ID: 26051582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to patient referral for Complementary and Alternative Medicines and its implications on interventions.
    Wong LY; Toh MP; Kong KH
    Complement Ther Med; 2010; 18(3-4):135-42. PubMed ID: 20688259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complementary and Alternative Medicine (CAM) in Uro-Oncology].
    Suhr J
    Onkologie; 2003 Oct; 26 Suppl 4():26-9. PubMed ID: 14605453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cancer patient between academic medicine and alternative medicine--therapeutic concepts].
    Nagel GA
    Arch Gynecol Obstet; 1995; 257(1-4):283-94. PubMed ID: 8579408
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic procedures in the Lukas Clinic, Arlsheim, Switzerland].
    Hoffmann J
    Gynakologe; 1994 Dec; 27(6):375-80. PubMed ID: 7843618
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrating a complementary medicine consultation for women undergoing chemotherapy.
    Ben-Arye E; Schiff E; Raz OG; Samuels N; Lavie O
    Int J Gynaecol Obstet; 2014 Jan; 124(1):51-4. PubMed ID: 24140221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies.
    Eschiti VS
    Integr Cancer Ther; 2007 Dec; 6(4):313-44. PubMed ID: 18048881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is integrative oncology and can it help my patients?
    Pineda MJ; Singh DK
    Obstet Gynecol Clin North Am; 2012 Jun; 39(2):285-312. PubMed ID: 22640716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
    Chrystal K; Allan S; Forgeson G; Isaacs R
    N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Referring to complementary and alternative medicine--a possible tool for implementation.
    Ben-Arye E; Frenkel M
    Complement Ther Med; 2008 Dec; 16(6):325-30. PubMed ID: 19028332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of human tumors.
    Sinkovics JG
    Pathobiol Annu; 1978; 8():241-84. PubMed ID: 364375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.